Present and future of breast cancer anti-Her-2-therapy
The paper describes a new class of molecular targeted antitumor agents against the molecules involved in carcinogenesis. It considers the basic drugs of this class and their combinations and evaluates the efficiency of their use in therapy for breast cancer.
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
ABV-press,
2014-07-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_e7c2aceb035344f1976b692f51a9d0a4 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a V. P. Letyagin |e author |
| 245 | 0 | 0 | |a Present and future of breast cancer anti-Her-2-therapy |
| 260 | |b ABV-press, |c 2014-07-01T00:00:00Z. | ||
| 500 | |a 1994-4098 | ||
| 500 | |a 1999-8627 | ||
| 500 | |a 10.17650/1994-4098-2011-0-2-41-44 | ||
| 520 | |a The paper describes a new class of molecular targeted antitumor agents against the molecules involved in carcinogenesis. It considers the basic drugs of this class and their combinations and evaluates the efficiency of their use in therapy for breast cancer. | ||
| 546 | |a RU | ||
| 690 | |a breast cancer | ||
| 690 | |a target therapy | ||
| 690 | |a Gynecology and obstetrics | ||
| 690 | |a RG1-991 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Опухоли женской репродуктивной системы, Vol 0, Iss 2, Pp 41-44 (2014) | |
| 787 | 0 | |n https://ojrs.abvpress.ru/ojrs/article/view/160 | |
| 787 | 0 | |n https://doaj.org/toc/1994-4098 | |
| 787 | 0 | |n https://doaj.org/toc/1999-8627 | |
| 856 | 4 | 1 | |u https://doaj.org/article/e7c2aceb035344f1976b692f51a9d0a4 |z Connect to this object online. |